GSK (NYSE: GSK) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.12 by 10.8 percent. This is a 12.82 percent increase over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $10.66 billion which beat the analyst consensus estimate of $10.33 billion by 3.19 percent. This is a 7.17 percent increase over sales of $9.95 billion the same period last year.